Wed, October 4, 2023
Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023
Thu, September 28, 2023
Wed, September 27, 2023

Edward White Reiterated (SNDX) at Strong Buy with Increased Target to $42 on, Oct 2nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-42-on-oct-2nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Edward White of HC Wainwright & Co., Reiterated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $38 to $42 on, Oct 2nd, 2023.

Edward has made no other calls on SNDX in the last 4 months.



There are 7 other peers that have a rating on SNDX. Out of the 7 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Edward


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Wednesday, August 16th, 2023
  • George Farmer of "Scotiabank" Initiated at Buy and Held Target at $39 on, Thursday, July 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $34 on, Wednesday, July 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, July 26th, 2023
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023

Publication Contributing Sources